188 related articles for article (PubMed ID: 20084478)
1. Geldanamycin selectively targets the nascent form of ERBB3 for degradation.
Gerbin CS; Landgraf R
Cell Stress Chaperones; 2010 Sep; 15(5):529-44. PubMed ID: 20084478
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90.
Xu W; Mimnaugh E; Rosser MF; Nicchitta C; Marcu M; Yarden Y; Neckers L
J Biol Chem; 2001 Feb; 276(5):3702-8. PubMed ID: 11071886
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
[TBL] [Abstract][Full Text] [Related]
4. Hsp90, not Grp94, regulates the intracellular trafficking and stability of nascent ErbB2.
Xu W; Mimnaugh EG; Kim JS; Trepel JB; Neckers LM
Cell Stress Chaperones; 2002 Jan; 7(1):91-6. PubMed ID: 11892991
[TBL] [Abstract][Full Text] [Related]
5. Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex.
Xu W; Yuan X; Xiang Z; Mimnaugh E; Marcu M; Neckers L
Nat Struct Mol Biol; 2005 Feb; 12(2):120-6. PubMed ID: 15643424
[TBL] [Abstract][Full Text] [Related]
6. Destabilization of the epidermal growth factor receptor (EGFR) by a peptide that inhibits EGFR binding to heat shock protein 90 and receptor dimerization.
Ahsan A; Ray D; Ramanand SG; Hegde A; Whitehead C; Rehemtulla A; Morishima Y; Pratt WB; Osawa Y; Lawrence TS; Nyati MK
J Biol Chem; 2013 Sep; 288(37):26879-86. PubMed ID: 23897823
[TBL] [Abstract][Full Text] [Related]
7. Flotillin depletion affects ErbB protein levels in different human breast cancer cells.
Asp N; Pust S; Sandvig K
Biochim Biophys Acta; 2014 Sep; 1843(9):1987-96. PubMed ID: 24747692
[TBL] [Abstract][Full Text] [Related]
8. Identification of an HSP90 modulated multi-step process for ERBB2 degradation in breast cancer cells.
Castagnola P; Bellese G; Birocchi F; Gagliani MC; Tacchetti C; Cortese K
Oncotarget; 2016 Dec; 7(51):85411-85429. PubMed ID: 27863425
[TBL] [Abstract][Full Text] [Related]
9. Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumors.
Ahsan A; Ramanand SG; Whitehead C; Hiniker SM; Rehemtulla A; Pratt WB; Jolly S; Gouveia C; Truong K; Van Waes C; Ray D; Lawrence TS; Nyati MK
Neoplasia; 2012 Aug; 14(8):670-7. PubMed ID: 22952420
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activity of WK88-1, a novel geldanamycin derivative, in gefitinib-resistant non-small cell lung cancers with Met amplification.
Jang WJ; Jung SK; Kang JS; Jeong JW; Bae MK; Joo SH; Park GH; Kundu JK; Hong YS; Jeong CH
Cancer Sci; 2014 Oct; 105(10):1245-53. PubMed ID: 25117641
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of phosphatidylinositol 4-kinase type IIbeta by interaction with Hsp90.
Jung G; Barylko B; Lu D; Shu H; Yin H; Albanesi JP
J Biol Chem; 2011 Apr; 286(14):12775-84. PubMed ID: 21330372
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.
Lang SA; Klein D; Moser C; Gaumann A; Glockzin G; Dahlke MH; Dietmaier W; Bolder U; Schlitt HJ; Geissler EK; Stoeltzing O
Mol Cancer Ther; 2007 Mar; 6(3):1123-32. PubMed ID: 17363505
[TBL] [Abstract][Full Text] [Related]
13. Pnck induces ligand-independent EGFR degradation by probable perturbation of the Hsp90 chaperone complex.
Deb TB; Zuo AH; Wang Y; Barndt RJ; Cheema AK; Sengupta S; Coticchia CM; Johnson MD
Am J Physiol Cell Physiol; 2011 May; 300(5):C1139-54. PubMed ID: 21325639
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 90 stabilization of ErbB2 expression is disrupted by ATP depletion in myocytes.
Peng X; Guo X; Borkan SC; Bharti A; Kuramochi Y; Calderwood S; Sawyer DB
J Biol Chem; 2005 Apr; 280(13):13148-52. PubMed ID: 15671027
[TBL] [Abstract][Full Text] [Related]
15. ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibition.
Dote H; Cerna D; Burgan WE; Camphausen K; Tofilon PJ
Cancer Res; 2005 Aug; 65(15):6967-75. PubMed ID: 16061682
[TBL] [Abstract][Full Text] [Related]
16. HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.
Safavi S; Järnum S; Vannas C; Udhane S; Jonasson E; Tomic TT; Grundevik P; Fagman H; Hansson M; Kalender Z; Jauhiainen A; Dolatabadi S; Stratford EW; Myklebost O; Eriksson M; Stenman G; Schneider-Stock R; Ståhlberg A; Åman P
Oncotarget; 2016 Jan; 7(1):433-45. PubMed ID: 26595521
[TBL] [Abstract][Full Text] [Related]
17. The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinase.
Stancato LF; Silverstein AM; Owens-Grillo JK; Chow YH; Jove R; Pratt WB
J Biol Chem; 1997 Feb; 272(7):4013-20. PubMed ID: 9020108
[TBL] [Abstract][Full Text] [Related]
18. ErbB2 overexpression in an ovarian cancer cell line confers sensitivity to the HSP90 inhibitor geldanamycin.
Smith V; Hobbs S; Court W; Eccles S; Workman P; Kelland LR
Anticancer Res; 2002; 22(4):1993-9. PubMed ID: 12174876
[TBL] [Abstract][Full Text] [Related]
19. The HSP90 inhibitor geldanamycin perturbs endosomal structure and drives recycling ErbB2 and transferrin to modified MVBs/lysosomal compartments.
Cortese K; Howes MT; Lundmark R; Tagliatti E; Bagnato P; Petrelli A; Bono M; McMahon HT; Parton RG; Tacchetti C
Mol Biol Cell; 2013 Jan; 24(2):129-44. PubMed ID: 23154999
[TBL] [Abstract][Full Text] [Related]
20. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants.
Prince TL; Kijima T; Tatokoro M; Lee S; Tsutsumi S; Yim K; Rivas C; Alarcon S; Schwartz H; Khamit-Kush K; Scroggins BT; Beebe K; Trepel JB; Neckers L
PLoS One; 2015; 10(10):e0141786. PubMed ID: 26517842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
